Bacterial Pneumonia
📧 Sign up to get email alerts when something new happens for Bacterial Pneumonia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2018-05-16EMA Withdrawn: Vibativ (telavancin) — Theravance Biopharma Ireland Umited
The EMA has withdrawn Vibativ (telavancin) from the market in the EU, a drug indicated for bacterial pneumonia and cross-infection.
-
EMA withdrawal · 2009-06-23EMA Application withdrawn: Factive — Menarini International Operations Luxembourg S.A.
The EMA withdrew the application for Factive by Menarini International Operations Luxembourg S.A., with therapeutic areas including chronic …